Radiology
Showing 361-380 of 677 Results
-
Noeen Malik, PhD
Industry Partnership Lead, Operations CRF-1701 Page Mill Rd, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordIndustry Partnership Lead
CRF, MIPS, Stanford School of Medicine, Stanford | May 2024 — present
Lead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/ -
Parag Mallick
Associate Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Current Research and Scholarly InterestsThe Mallick Lab is focused on using integrative, multi-omic approaches to model the processes that govern cellular dynamics and to use those models to discover cancer biomarkers and molecular mechanisms.
-
Wilfred Manzano
Clinical Instructor, Radiology
BioRadiology attending, clinical instructor
-
Michael P. Marks, MD
Professor of Radiology (General Radiology), Emeritus
Current Research and Scholarly InterestsInterventional neuroradiology; cerebral arteriovenous malformations; stroke treatment and imaging; cerebral aneurysms
-
Lynne Martin, MD
Clinical Assistant Professor, Radiology
BioDr. Martin is an interventional radiologist with Stanford Health Care Interventional Radiology. She is also a clinical instructor in the Department of Radiology, Division of Nuclear Medicine and Molecular Imaging at Stanford University School of Medicine.
Dr. Martin specializes in interventional oncology (minimally invasive cancer treatments). She diagnoses and treats venous (vein) disease, including venous occlusion (when a vein becomes narrowed or blocked by nearby structures), deep vein thrombosis (DVT), and vascular malformations (abnormal development of blood vessels). She also focuses on the management of cirrhosis (severe scarring of the liver) and portal hypertension (elevated pressure in a large abdominal vein). Additionally, she treats women’s health issues, such as fallopian tube blockages, chronic pelvic pain, pelvic venous disease, and uterine fibroids. She is a specialist provider for patients with HHT and pulmonary AVMs as well as patients with vascular malformations (arterial, venous, venolymphatic).
Her research interests include treatments for portal vein thrombosis (clotting), liver cancer, and health care disparities. She has also studied intra-arterial corticosteroid treatment for inflammatory bowel disease. In addition, she has explored the use of bronchial artery embolization (blocking a blood vessel) for the treatment of hemoptysis (coughing up blood) in people with cystic fibrosis.
Dr. Martin twice received the Society of Interventional Oncology (SIO) Scholarship Award. She won first place in SIO’s Artificial Intelligence Hackathon. She has also twice received the Etta Kalin Moskowitz Fund Research Award.
Dr. Martin has published in peer-reviewed journals, including the Journal of Clinical Medicine, Neuropeptides, and Journal of Vascular and Interventional Radiology. She has delivered presentations at a number of professional society meetings, including the SIO, the Society of Interventional Radiology (SIR), and the Radiological Society of North America (RSNA).
Dr. Martin is a member of several professional groups, including SIO, SIR, and RSNA. She also serves on committees such as SIO’s Education Committee and Stanford’s Performance Improvement Committee. -
Tarik F. Massoud, MD, PhD
Professor of Radiology (Neuroimaging and Neurointervention)
Current Research and Scholarly InterestsMy current interests are in molecular and translational imaging of the brain especially in neuro-oncology and cerebrovascular diseases, experimental aspects of neuroimaging, clinical neuroradiology, neuroradiological anatomy, and research education and academic training of radiologists and scientists.
-
Charles McGrath
Postdoctoral Scholar, Radiological Sciences Laboratory
BioCharles McGrath is a postdoctoral scholar at the Radiological Sciences Laboratory (RSL) at Stanford University, working with Dr. Daniel Ennis on cardiovascular magnetic resonance imaging. His research focuses on flow imaging, particularly 4D flow MRI and the quantification of complex hemodynamics and on building open, reproducible simulation tools that support methods development across the cardiovascular MR community.
He earned his Dr.Sc. in Biomedical Engineering from ETH Zurich in 2024, advised by Prof. Sebastian Kozerke, with a thesis on simulation and optimal sequence design for lower-field cardiovascular MRI. During his doctoral work, he developed referenceless 4D flow MRI techniques using radial balanced SSFP at lower field strengths and contributed to widely used open-source tools for cardiovascular MR simulation (CMRsim) and sequence design (CMRseq). He is an active advocate for open science in the MR community and continues to develop and maintain these tools as part of his research practice. He previously received an M.Sc. with distinction in Biomedical Engineering (Medical Physics) jointly from ETH Zurich, and a B.A.Sc. in Engineering Physics from the University of British Columbia. -
Jennifer A McNab
Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)
Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.
